Avego BioScience Capital Fund II, L.P.
Avego BioScience Capital Fund II, L.P. is a venture capital fund based in Alpharetta, Georgia. According to its most recent Form D, filed Apr 6, 2026, it has sold $60,000,000 of interests to 1 investor since its first sale in Apr 2026. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Balaji Venkataraman; Avego BioScience Capital GP II, LLC; Alyssa Romano.
- Total raised
- $60,000,000Cumulative sales reported on Form D
- Investors
- 1
- First sale
- Apr 1, 2026
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Balaji Venkataraman; Avego BioScience Capital GP II, LLC; Alyssa Romano
- Latest Form D
- Apr 6, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Avego BioScience Capital Fund II, L.P.
What is the minimum investment for Avego BioScience Capital Fund II, L.P.?
Avego BioScience Capital Fund II, L.P.'s latest Form D, filed Apr 6, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Avego BioScience Capital Fund II, L.P.?
Avego BioScience Capital Fund II, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Avego BioScience Capital Fund II, L.P. raised?
Avego BioScience Capital Fund II, L.P. reports $60,000,000 sold from 1 investor on its Form D filed Apr 6, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Avego BioScience Capital Fund II, L.P. based?
Avego BioScience Capital Fund II, L.P. is based in Alpharetta, Georgia.
When did Avego BioScience Capital Fund II, L.P. launch?
Avego BioScience Capital Fund II, L.P. reports its first sale in Apr 2026.
Size compared with every venture capital fund
Raised more than 94% of the 47 venture capital funds based in Georgia, and more than 97% of all 14,901 that report sales.